<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD005320.pub2" GROUP_ID="MUSKEL" ID="243404031611110729" MERGED_FROM="" MODIFIED="2008-11-07 19:30:27 +0100" MODIFIED_BY="Elizabeth Tanjong Ghogomu" NOTES="&lt;p&gt;Exported from Review Manager 4.2.8&lt;br&gt;Exported from Review Manager 4.2.7&lt;br&gt;Exported from Review Manager 4.2.6&lt;br&gt;Exported from Review Manager 4.2.2&lt;br&gt;Exported from Review Manager 4.2.3&lt;br&gt;&lt;/p&gt;" NOTES_MODIFIED="2008-11-07 13:26:20 -0500" NOTES_MODIFIED_BY="Elizabeth Tanjong Ghogomu" REVIEW_NO="A015-R" REVMAN_SUB_VERSION="5.0.16" REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="3.0">
<COVER_SHEET MODIFIED="2008-11-07 13:26:20 -0500" MODIFIED_BY="Elizabeth Tanjong Ghogomu">
<TITLE>Operative and non-operative treatment options for dislocation of the hip following total hip arthroplasty</TITLE>
<CONTACT>
<PERSON ID="18332" ROLE="AUTHOR">
<PREFIX>Mr</PREFIX>
<FIRST_NAME>Riaz</FIRST_NAME>
<MIDDLE_INITIALS>JK</MIDDLE_INITIALS>
<LAST_NAME>Khan</LAST_NAME>
<SUFFIX>FRCS</SUFFIX>
<POSITION>Senior Lecturer</POSITION>
<EMAIL_1>rjkkhan@gmail.com</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Trauma and Orthopaedics</DEPARTMENT>
<ORGANISATION>University of Western Australia</ORGANISATION>
<ADDRESS_1>1/14-16 Hamersley Street</ADDRESS_1>
<ADDRESS_2>Cottesloe</ADDRESS_2>
<CITY>Perth</CITY>
<ZIP>6011</ZIP>
<REGION>Western Australia</REGION>
<COUNTRY CODE="AU">Australia</COUNTRY>
<PHONE_1>+61 404 271500</PHONE_1>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
</CONTACT>
<CREATORS MODIFIED="2008-11-07 13:26:20 -0500" MODIFIED_BY="Elizabeth Tanjong Ghogomu">
<PERSON ID="18332" ROLE="AUTHOR">
<PREFIX>Mr</PREFIX>
<FIRST_NAME>Riaz</FIRST_NAME>
<MIDDLE_INITIALS>JK</MIDDLE_INITIALS>
<LAST_NAME>Khan</LAST_NAME>
<SUFFIX>FRCS</SUFFIX>
<POSITION>Senior Lecturer</POSITION>
<EMAIL_1>rjkkhan@gmail.com</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Trauma and Orthopaedics</DEPARTMENT>
<ORGANISATION>University of Western Australia</ORGANISATION>
<ADDRESS_1>1/14-16 Hamersley Street</ADDRESS_1>
<ADDRESS_2>Cottesloe</ADDRESS_2>
<CITY>Perth</CITY>
<ZIP>6011</ZIP>
<REGION>Western Australia</REGION>
<COUNTRY CODE="AU">Australia</COUNTRY>
<PHONE_1>+61 404 271500</PHONE_1>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="3CEBE4B682E26AA200E154978896F2E5" ROLE="AUTHOR">
<PREFIX>Mr</PREFIX>
<FIRST_NAME>Richard</FIRST_NAME>
<MIDDLE_INITIALS>L</MIDDLE_INITIALS>
<LAST_NAME>Carey Smith</LAST_NAME>
<SUFFIX/>
<POSITION>Allograft Fellow</POSITION>
<EMAIL_1>richardcareysmith@msn.com</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Trauma and Orthopaedic Surgery</DEPARTMENT>
<ORGANISATION>Perth Orthopaedic Institute</ORGANISATION>
<ADDRESS_1>4/5 Salvado St</ADDRESS_1>
<ADDRESS_2>Cottesloe</ADDRESS_2>
<CITY>Perth</CITY>
<ZIP>6011</ZIP>
<REGION>Western Australia</REGION>
<COUNTRY CODE="AU">Australia</COUNTRY>
<PHONE_1>0408949536</PHONE_1>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="8305273782E26AA20029B854731FA4F3" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Renuka</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Alakeson</LAST_NAME>
<SUFFIX/>
<POSITION>Research fellow</POSITION>
<EMAIL_1>andrew.martin21@bigpond.com</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Trauma and Orthopaedic Surgery</DEPARTMENT>
<ORGANISATION>Perth Orthopaedic Institute</ORGANISATION>
<ADDRESS_1>Gate 3</ADDRESS_1>
<ADDRESS_2>Verdun Street</ADDRESS_2>
<CITY>Perth</CITY>
<ZIP>6011</ZIP>
<REGION>Nedlands</REGION>
<COUNTRY CODE="AU">Australia</COUNTRY>
<PHONE_1>08 9386 6211</PHONE_1>
<PHONE_2/>
<FAX_1>08 9346 6462</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="17073" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Daniel</FIRST_NAME>
<MIDDLE_INITIALS>P</MIDDLE_INITIALS>
<LAST_NAME>Fick</LAST_NAME>
<SUFFIX/>
<POSITION>Research Fellow</POSITION>
<EMAIL_1>danfick@cyllene.uwa.edu.au</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Orthopaedics</DEPARTMENT>
<ORGANISATION>University of Western Australia</ORGANISATION>
<ADDRESS_1>17a Pearse St</ADDRESS_1>
<ADDRESS_2/>
<CITY>Cottesloe</CITY>
<ZIP>6011</ZIP>
<REGION>WA</REGION>
<COUNTRY CODE="AU">Australia</COUNTRY>
<PHONE_1>+61421582907</PHONE_1>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="17081" ROLE="AUTHOR">
<PREFIX>Prof</PREFIX>
<FIRST_NAME>David</FIRST_NAME>
<MIDDLE_INITIALS>J</MIDDLE_INITIALS>
<LAST_NAME>Wood</LAST_NAME>
<SUFFIX/>
<POSITION>Professor</POSITION>
<EMAIL_1>dwood@cyllene.uwa.edu.au</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Trauma and Orthopaedics</DEPARTMENT>
<ORGANISATION>Perth Orthopaedic Institute</ORGANISATION>
<ADDRESS_1/>
<ADDRESS_2/>
<CITY>Perth</CITY>
<ZIP/>
<REGION/>
<COUNTRY CODE="AU">Australia</COUNTRY>
<PHONE_1/>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
</CREATORS>
<DATES MODIFIED="2008-11-07 13:02:45 -0500" MODIFIED_BY="[Empty name]">
<UP_TO_DATE>
<DATE DAY="16" MONTH="8" YEAR="2006"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="16" MONTH="8" YEAR="2006"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="15" MONTH="11" YEAR="2008"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="2" YEAR="2005"/>
<REVIEW_PUBLISHED ISSUE="1" YEAR="2006"/>
<LAST_CITATION_ISSUE ISSUE="4" YEAR="2006"/>
</DATES>
<WHATS_NEW MODIFIED="2008-11-07 13:02:00 -0500" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2008-11-07 13:02:00 -0500" MODIFIED_BY="[Empty name]">
<DATE DAY="7" MONTH="11" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format.</P>
<P>CMSG ID: A015-R</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2008-11-07 13:02:27 -0500" MODIFIED_BY="[Empty name]"/>
<SOURCES_OF_SUPPORT>
<INTERNAL_SOURCES/>
<EXTERNAL_SOURCES>
<SOURCE>
<NAME>Library services, Royal Australasian College of Surgeons</NAME>
<COUNTRY CODE="AU">Australia</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</EXTERNAL_SOURCES>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2008-11-07 13:04:19 -0500" MODIFIED_BY="[Empty name]">
<SUMMARY>
<TITLE>Treatments for dislocation of the hip after Total Hip Replacement surgery</TITLE>
<SUMMARY_BODY>
<P>This summary of a Cochrane review presents what we know from research about the effects of treatments for dislocation of the hip after total hip replacement surgery. The review shows that:</P>
<P>It is not known what the best treatment for dislocation of the hip after Total Hip Replacement surgery is. This is because no evidence was found that looked at the treatments for dislocation of the hip after surgery.</P>
<P>
<B>What are the treatments for dislocation of the hip after Total Hip Replacement surgery?</B>
<BR/>In total hip replacement surgery, the whole hip joint can be replaced by an artificial joint or hip. About 3 out of 100 people who have this surgery will dislocate their hip. Dislocating a hip causes much pain and other problems. There are many ways to fix a dislocated hip. Usually, the first time a dislocation occurs the hip is put into a cast or brace. But repeated dislocations usually need to be fixed with surgery. Unfortunately, the causes for dislocation are many and some are not known making it difficult to know the best way to fix it.</P>
<P>
<B>What are the results of this review?</B>
<BR/>No evidence was found that looked at the treatments for dislocation of the hip after surgery.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT>
<ABS_BACKGROUND>
<P>Dislocation following hip replacement is associated with significant morbidity and functional cost. The cause is usually multifactorial. A variety of treatment options are available which can broadly be classified into operative and non-operative. </P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES>
<P>To determine the best methods of treatment of recurrent dislocation following total hip replacement.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY>
<P>The following databases were searched until August 2006: MEDLINE, EMBASE, CINAHL, the Cochrane Central Register of Controlled Trials (CENTRAL), Health Technology Assessment database (HTA), Database of Abstracts of Reviews of Effectiveness (DARE), International Standard Randomised Controlled Trial Number Register (ISRCTN), and MetaRegister of Controlled Trials (mRCT).</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA>
<P>Randomised and quasi-randomised trials comparing operative and non-operative treatments for recurrent dislocation following total hip replacement.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION>
<P>Two independent reviewers applied the inclusion criteria to identified studies.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS>
<P>Searches identified 269 studies. None fulfilled the inclusion criteria.</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS>
<P>The authors invite researchers to perform RCTs comparing different treatment options for recurrent dislocation of the hip. The heterogeneity of the population and variety of underlying causes would favour a multi-centre study to achieve an adequate sample size.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2008-11-07 13:04:19 -0500" MODIFIED_BY="[Empty name]">
<BACKGROUND>
<P>Dislocation is a devastating complication after total hip arthroplasty, with significant morbidity and functional cost to the patient (<LINK REF="REF-Chandler-1982" TYPE="REFERENCE">Chandler 1982</LINK>). The prevalence following primary joint replacement is around 3% (<LINK REF="REF-Woo-1982" TYPE="REFERENCE">Woo 1982</LINK>), and the cumulative risk increases steadily with time (<LINK REF="REF-Berry-2004" TYPE="REFERENCE">Berry 2004</LINK>). Following revision surgery the rate increases to between 5 and 20% (<LINK REF="REF-Turner-1994" TYPE="REFERENCE">Turner 1994</LINK>; <LINK REF="REF-Woo-1982" TYPE="REFERENCE">Woo 1982</LINK>; <LINK REF="REF-Alberton-2002" TYPE="REFERENCE">Alberton 2002</LINK>; <LINK REF="REF-Williams-1982" TYPE="REFERENCE">Williams 1982</LINK>; <LINK REF="REF-Paterno-1997" TYPE="REFERENCE">Paterno 1997</LINK>). In addition, the dislocation rate following revision surgery for dislocation is disappointingly high (<LINK REF="REF-Daly-1992" TYPE="REFERENCE">Daly 1992</LINK>). It is seen more frequently in patients who have had previous hip surgery (<LINK REF="REF-Lewinnek-1978" TYPE="REFERENCE">Lewinnek 1978</LINK>; <LINK REF="REF-Fackler-1980" TYPE="REFERENCE">Fackler 1980</LINK>), with smaller head sizes (<LINK REF="REF-Alberton-2002" TYPE="REFERENCE">Alberton 2002</LINK>), patients over the age of 80 years (<LINK REF="REF-Ekelund-1992" TYPE="REFERENCE">Ekelund 1992</LINK>), arthroplasty following hip fracture (<LINK REF="REF-Bystrom-2003" TYPE="REFERENCE">Bystrom 2003</LINK>), in neuromuscular disorders (<LINK REF="REF-Cabanela-2000" TYPE="REFERENCE">Cabanela 2000</LINK>) and in patients with cognitive dysfunction (<LINK REF="REF-Woo-1982" TYPE="REFERENCE">Woo 1982</LINK>; <LINK REF="REF-Woolson-1999" TYPE="REFERENCE">Woolson 1999</LINK>).</P>
<P>Recurrent dislocation is defined as two or more dislocations. Causes of dislocation of total hip arthroplasty have been classified into positional (type I), soft tissue imbalance (type II) and component malposition (type III) (<LINK REF="REF-Dorr-1983" TYPE="REFERENCE">Dorr 1983</LINK>). First time dislocations (particularly type I) are often treated with closed reduction and immobilisation in a cast or brace, and patient education (<LINK REF="REF-Berry-2001" TYPE="REFERENCE">Berry 2001</LINK>; <LINK REF="REF-Dorr-1983" TYPE="REFERENCE">Dorr 1983</LINK>; <LINK REF="REF-Ritter-1976" TYPE="REFERENCE">Ritter 1976</LINK>). Recurrent dislocation, (particularly type III) often require revision surgery (<LINK REF="REF-Dorr-1983" TYPE="REFERENCE">Dorr 1983</LINK>). Causes of dislocation following THA are often multi-factorial or unknown. The reasons for early versus late dislocations may also be different. In addition to this, it has also been shown that the underlying diagnosis (e.g. osteonecrosis, previous hip fracture, inflammatory arthritis) for the patient undergoing hip arthroplasty may influence the risk of dislocation (<LINK REF="REF-Berry-2004" TYPE="REFERENCE">Berry 2004</LINK>). </P>
<P>It is generally accepted that the underlying reason for the instability should be sought and rectified where possible (<LINK REF="REF-Ali-Khan-1981" TYPE="REFERENCE">Ali Khan 1981</LINK>). However causation is often multifactorial, and each potential cause should not be perceived in isolation (<LINK REF="REF-Joshi-1998" TYPE="REFERENCE">Joshi 1998</LINK>). Even when a cause, such as impingement is identified and treated, the results can be sub-optimal suggesting additional methods may be needed to achieve stability (<LINK REF="REF-Daly-1992" TYPE="REFERENCE">Daly 1992</LINK>). </P>
<P>Techniques that have been employed to improve the results of revision surgery for dislocation can be broadly classified into those addressing the acetabular liner, femoral head size, and bony or soft tissue reconstruction. Variations of acetabular liner include the use of constrained implants (<LINK REF="REF-Shapiro-2003" TYPE="REFERENCE">Shapiro 2003</LINK>; <LINK REF="REF-Bremner-2003" TYPE="REFERENCE">Bremner 2003</LINK>; <LINK REF="REF-Lombardi-1991" TYPE="REFERENCE">Lombardi 1991</LINK>; <LINK REF="REF-Anderson-1994" TYPE="REFERENCE">Anderson 1994</LINK>; <LINK REF="REF-Su-2001" TYPE="REFERENCE">Su 2001</LINK>; <LINK REF="REF-Stanton-2002" TYPE="REFERENCE">Stanton 2002</LINK>; <LINK REF="REF-Shrader-2003" TYPE="REFERENCE">Shrader 2003</LINK>; <LINK REF="REF-Ranawat-2000" TYPE="REFERENCE">Ranawat 2000</LINK>), elevated-rim liners (<LINK REF="REF-Cobb-1996" TYPE="REFERENCE">Cobb 1996</LINK>) and augmentation wedges (<LINK REF="REF-Olerud-1985" TYPE="REFERENCE">Olerud 1985</LINK>, <LINK REF="REF-Charlwood-2002" TYPE="REFERENCE">Charlwood 2002</LINK>). Femoral head size may be increased by conversion to a bipolar hemiarthroplasty (<LINK REF="REF-Parvizi-2000" TYPE="REFERENCE">Parvizi 2000</LINK>) and the use of large or jumbo femoral heads (Kelley 1998, <LINK REF="REF-Beaule-2002" TYPE="REFERENCE">Beaule 2002</LINK>; <LINK REF="REF-Bystrom-2003" TYPE="REFERENCE">Bystrom 2003</LINK>). Reconstructive procedures include trochanteric advancement (<LINK REF="REF-Kaplan-1987" TYPE="REFERENCE">Kaplan 1987</LINK>) and soft tissue reconstruction (<LINK REF="REF-Stromsoe-1995" TYPE="REFERENCE">Stromsoe 1995</LINK>; <LINK REF="REF-Mahoney-2003" TYPE="REFERENCE">Mahoney 2003</LINK>; <LINK REF="REF-Fujishiro-2003" TYPE="REFERENCE">Fujishiro 2003</LINK>). The variety of the treatment options may reflect the lack of success surgeons have had in tackling this issue.<BR/> </P>
</BACKGROUND>
<OBJECTIVES>
<P>To identify and summarise the evidence from randomised controlled trials assessing the clinical efficacy and safety of different interventions in the treatment of dislocation of the hip following total hip arthroplasty.</P>
<P>The null hypotheses to be tested are:<BR/>1. There is no difference in outcome between different non-operative treatment methods<BR/>2. There is no difference in outcome between non-operative and operative treatment methods<BR/>3. There is no difference in outcome between different operative treatment methods</P>
</OBJECTIVES>
<METHODS MODIFIED="2008-11-07 13:04:19 -0500" MODIFIED_BY="[Empty name]">
<SELECTION_CRITERIA>
<CRIT_STUDIES>
<P>All randomised controlled trials comparing treatment options for dislocation of the hip following total hip arthroplasty were considered for inclusion. Quasi-randomised trials and trials in which the treatment allocation was inadequately concealed were also considered if the remaining methodology was of a satisfactory standard.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS>
<P>All patients who have had a total hip arthroplasty, primary or revision, and sustained a dislocation were considered for inclusion. First time and recurrent dislocations were included.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS>
<P>The non-operative interventions are treatment with a hip spica cast or hip abduction brace, and patient education. The operative interventions are treatment with constrained implants, acetabular augmentation or elevated rim, bipolar hemiarthroplasty, large or jumbo femoral heads, trochanteric advancement and soft tissue reconstructions.</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES>
<P>Primary measures:<BR/>Dislocation rate<BR/>Re-operation rate<BR/>Operative measures including: length of surgery, operative blood loss, post-operative blood transfusion<BR/>Pain and discomfort<BR/>Complications related to the implant, periprosthetic fractures, others (as detailed in each individual study)</P>
<P>Secondary measures:<BR/>Malposition of cup<BR/>Malposition of stem<BR/>Length of hospital stay (days)<BR/>Discharge destination<BR/>Walking aids at discharge<BR/>Range of movement of the hip<BR/>Mobility (use of walking aids)<BR/>Health related quality of life measures<BR/>Cup loosening<BR/>Femoral stem loosening<BR/>Heterotopic ossification<BR/>Polyethylene wear<BR/>Survival rate of the prosthesis<BR/>Mortality<BR/>Patient education of techniques to reduce risk of dislocation</P>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2008-11-07 13:04:19 -0500" MODIFIED_BY="[Empty name]">
<P>Relevant RCTs were identified by application of a general search strategy developed by modification of that recommended by Dickersin (1994) and Haynes (1994) in collaboration with the CMSG trials search coordinator. The following databases were searched: MEDLINE (1966-August 2006), EMBASE (1980-August 2006), CINAHL (1982-August 2006), the Cochrane Central Register of Controlled Trials (CENTRAL, The Cochrane Library Issue 3, 2006), Health Technology Assessment database (HTA), Database of Abstracts of Reviews of Effectiveness (DARE), International Standard Randomised Controlled Trial Number Register (ISRCTN), and MetaRegister of Controlled Trials (mRCT).</P>
<P>In MEDLINE (OVID-WEB) the following subject specific search was combined with all three levels of the optimal trial search strategy (<LINK REF="REF-Higgins-2005" TYPE="REFERENCE">Higgins 2005</LINK>):see <LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK>.</P>
<P>Bibliographies of retrieved studies were investigated and the Science Citation Index used to identify articles that quote the original study (in an effort to find unidentified trials).</P>
<P>Unpublished data was sought from conference proceedings, Internet citations and personal communications. Where possible, authors of published trials were contacted to clarify or provide additional information.</P>
<P>Articles of all languages were considered and translated where necessary.</P>
</SEARCH_METHODS>
<DATA_COLLECTION>
<P>Two independent reviewers assessed the potential eligibility for inclusion in the review based on the inclusion criteria. Studies that clearly failed to meet the inclusion criteria were not reviewed. The reviewers extracted data separately on to modified pro forma data abstraction forms (template provided by the Musculoskeletal Group) without masking of the study names, authors, institutions or journal of publication. Any differences were resolved by discussion.</P>
<P>In the event of published trials being identified, the data will be analysed in the following manner: quality of included trials will be evaluated independently by the reviewers, using criteria adapted from the Cochrane Handbook (<LINK REF="REF-Higgins-2005" TYPE="REFERENCE">Higgins 2005</LINK>) and Jadad (<LINK REF="REF-Jadad-1996" TYPE="REFERENCE">Jadad 1996</LINK>). The main assessment of methodology is the quality of allocation concealment. The following aspects of internal and external validity will be assessed:</P>
<P>Selection biases<BR/>1. Was there clear concealment of allocation?<BR/>2. Were the inclusion and exclusion criteria clearly defined?<BR/>3. Were the treatment and control groups adequately described at entry and if so were the groups well matched or appropriate covariance adjustment made?</P>
<P>Performance biases<BR/>4. Were the surgeons experienced in both operations prior to the trial?<BR/>5. Were the care programs other than trial options identical?</P>
<P>Detection biases<BR/>6. Were the outcome measures clearly defined in the text with a definition of ambiguous terms encountered e.g.. Minimally invasive.<BR/>7. Were the outcome assessors blind to assignment status?<BR/>8. Where patients blind to assignment status?<BR/>9. Was a long-term follow-up performed? Minimum of 1 year.<BR/>10. Was the timing of outcome assessment in both groups comparable and appropriate?<BR/>11. Was loss to follow-up reported and if so were less than five per cent of patients lost to follow up?</P>
<P>Statistics<BR/>12. Was a sample size calculation performed?<BR/>13. Did the trial include an intention-to-treat analysis?</P>
<P>Further information will be obtained from the primary author if the published article provides inadequate information. </P>
<P>The following methods were planned for the review had there been any trials that met the inclusion criteria:<BR/>For each study, relative risks and 95% confidence limits will be calculated for dichotomous outcomes, and weighted mean differences and 95% confidence limits calculated for continuous outcomes. Results from individually randomised trials will be pooled wherever possible using the fixed effects model. A random effects model will be used where there is statistical or graphical evidence of heterogeneity.</P>
<P>In addition, a further ranking based on the level of evidence will be performed in the manner described by Tugwell (<LINK REF="REF-Tugwell-2004" TYPE="REFERENCE">Tugwell 2004</LINK>) and approved by the CMSG editorial team. A simplified ranking will also be used to grade the strength of scientific evidence for the trial intervention. In decreasing order :</P>
<P>Platinum level<BR/>The Platinum ranking is given to evidence that meets the following criteria as reported:<BR/>is a published systematic review that has at least two individual controlled trials each satisfying the following:<BR/>1. Sample sizes of at least 50 per group. If they do not find a statistically significant difference, they are adequately powered for a 20% relative difference in the relevant outcome.<BR/>2. Blinding of patients and assessors for outcomes. <BR/>3. Handling of withdrawals &gt;80% follow up (imputations based on methods such as Last Observation Carried Forward (LOCF) acceptable). <BR/>4. Concealment of treatment allocation.</P>
<P>Gold level<BR/>The Gold ranking is given to evidence if at least one randomised clinical trial meets all of the following criteria for the major outcome(s) as reported:<BR/>1. Sample sizes of at least 50 per group. If they do not find a statistically significant difference, they are adequately powered for a 20% relative difference in the relevant outcome.<BR/>2. Blinding of patients and assessors for outcomes.<BR/>3. Handling of withdrawals &gt; 80% follow up (imputations based on methods such as Last Observation Carried Forward (LOCF) acceptable).<BR/>4. Concealment of treatment allocation.</P>
<P>Silver level<BR/>The Silver ranking is given to evidence if a systematic review or randomised trial that does not meet the above criteria. Silver ranking would also include evidence from at least one study of non-randomised cohorts who did and did not receive the therapy or evidence from at least one high quality case-control study. A randomised trial with a 'head-to-head' comparison of agents is considered Silver level ranking unless a reference is provided to a comparison of one of the agents to placebo showing at least a 20% relative difference. </P>
<P>Bronze level<BR/>The bronze ranking is given to evidence if at least one high quality case series without controls (including simple before/after studies in which the patient acts as their own control) or is derived from expert opinion based on clinical experience without reference to any of the foregoing (for example, argument from physiology, bench research or first principles).</P>
<P>Clinical relevance tables <BR/>Clinical relevance tables will be compiled under additional tables to improve the readability of the review. For dichotomous outcomes, the number needed to treat will be calculated from the control group event rate and the relative risk using the Visual Rx NNT calculator (<LINK REF="REF-Cates-2004" TYPE="REFERENCE">Cates 2004</LINK>). Continuous outcome tables will be presented under additional tables. Absolute benefit will be calculated as the improvement in the intervention group minus the improvement in the control group, in the original units. Relative difference in the change from baseline will be calculated as the absolute benefit divided by the baseline mean of the control group. The NNT for continuous measures will also be calculated.</P>
</DATA_COLLECTION>
</METHODS>
<RESULTS>
<STUDY_DESCRIPTION>
<P>Searches identified 269 studies. None fulfilled the inclusion criteria.</P>
</STUDY_DESCRIPTION>
<STUDY_QUALITY>
<P>There are as yet no published RCTs included in this review.</P>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS>
<P>There are no published results to report from RCTs investigating treatment options for recurrent dislocation of the hip.</P>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION>
<P>Given that dislocation following total hip arthroplasty has such a high functional as well as economic cost, there is a need for further research to optimize the treatment of this condition. Dislocation of the hip following total hip arthroplasty is common, and its management can be difficult. There are no studies available to guide non-operative treatment and rehabilitation. Results from studies on large femoral heads and constrained cups are promising and appear to minimise the risk of re-dislocation. With constrained cups this may be at the potential cost of early re-revision due to increased micromotion and early loosening.</P>
<P>Despite the large number of case series of recurrent dislocations in the literature, there remains to be published a comparative study of different techniques.</P>
</DISCUSSION>
<CONCLUSIONS>
<IMPLICATIONS_PRACTICE>
<P>There are various operative and non-operative techniques described for dealing with the dislocating total hip arthroplasty. The efficacy of these treatment options are yet to be compared by randomised controlled trials.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH>
<P>The authors invite researchers to conduct randomised controlled trials comparing operative and non-operative methods for the treatment of the dislocating THA. The heterogeneity of the population and variety of underlying causes is problematic. In order to achieve homogeneous groups for valid comparisons studies would need to be multicentric. Ideally all dislocations would be recorded in national joint registries to give a true indication of the size of the problem. Unanswered questions regarding non operative management include duration of use of abduction braces. And a useful comparison of operative management would be very large metal on metal heads (44 mm+) and constrained cups.</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS>
<P>We thank the following for their helpful comments at editorial review: Lara Maxwell, Leanne Morton. Thanks to Louise Falzon for assistance with the search strategy.<BR/>
</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST>
<P>None known</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS>
<P>Riaz Khan initiated and designed the study with the help of Nuki Alakeson and Dan Fick. All authors have contributed to the writing of the protocol. Riaz Khan is the guarantor of the review.</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF/>
<PUBLIC_NOTES/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2008-11-07 13:06:56 -0500" MODIFIED_BY="[Empty name]">
<STUDIES>
<INCLUDED_STUDIES/>
<EXCLUDED_STUDIES>
<STUDY DATA_SOURCE="PUB" ID="STD-Atlihan-2002" NAME="Atlihan 2002" YEAR="2002">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Atlihan D, Bozkurt M</AU>
<TI>Total hip arthroplasty in neglected congenital high dislocation of the hip. A comparison of four different surgical techniques</TI>
<SO>Hip International</SO>
<YR>2002</YR>
<VL>12</VL>
<NO>3</NO>
<PG>308-313</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kelley-1998" NAME="Kelley 1998" YEAR="1998">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kelley SS, Lachiewicz PF, Hickman JM, Paterno SM</AU>
<TI>Relationship of femoral head and acetabular size to the prevalence of dislocation</TI>
<SO>Clin Orthop</SO>
<YR>1998</YR>
<VL>355</VL>
<PG>163-70</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Peak-2005" NAME="Peak 2005" YEAR="2005">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Peak EL, Parvizi J, Ciminiello M, Purtill JJSharkey PF, Hozack WJ, Rothman RH</AU>
<TI>The role of patient restrictions in reducing the prevalence of early dislocation following total hip arthroplasty. A randomized, prospective study</TI>
<SO>J Bone Joint Surg Am</SO>
<YR>2005</YR>
<VL>87</VL>
<NO>2</NO>
<PG>247-53</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Toomey-2001" NAME="Toomey 2001" YEAR="2001">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Toomey SD, Hopper RH, Mc Auley JP, Engh CA</AU>
<TI>Modular component exchange for treatment of recurrent dislocation of a total hip replacement in selected patients</TI>
<SO>J Bone Joint Surg Am</SO>
<YR>2001</YR>
<VL>83</VL>
<NO>10</NO>
<PG>1529-33</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES/>
<ONGOING_STUDIES/>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2008-11-07 13:06:56 -0500" MODIFIED_BY="[Empty name]">
<ADDITIONAL_REFERENCES MODIFIED="2008-11-07 13:06:56 -0500" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Alberton-2002" NAME="Alberton 2002" TYPE="JOURNAL_ARTICLE">
<AU>Alberton GM, High WA, Morrey BF</AU>
<TI>Dislocation after revision total hip arthroplasty</TI>
<SO>J Bone Joint Surg Am</SO>
<YR>2002</YR>
<VL>84</VL>
<NO>10</NO>
<PG>1788-92</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ali-Khan-1981" NAME="Ali Khan 1981" TYPE="JOURNAL_ARTICLE">
<AU>Ali Khan MA, Brakenbury PH, Reynolds ISR</AU>
<TI>Dislocation following total hip replacement</TI>
<SO>J Bone Joint Surg Br</SO>
<YR>1981</YR>
<VL>63</VL>
<NO>2</NO>
<PG>214-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Anderson-1994" NAME="Anderson 1994" TYPE="JOURNAL_ARTICLE">
<AU>Anderson MJ, Murray WR, Skinner HB</AU>
<TI>Constrained acetabular components</TI>
<SO>J Arthroplasty</SO>
<YR>1994</YR>
<VL>9</VL>
<NO>1</NO>
<PG>17-23</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Beaule-2002" NAME="Beaule 2002" TYPE="JOURNAL_ARTICLE">
<AU>Beaule PE, Schmalzried TP, Udomkiat P, Amstutz HC</AU>
<TI>Jumbo femoral head for the treatment of recurrent dislocation following total hip replacement</TI>
<SO>J Bone Joint Surg Am</SO>
<YR>2002</YR>
<VL>84</VL>
<NO>2</NO>
<PG>256-63</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Berry-2001" NAME="Berry 2001" TYPE="JOURNAL_ARTICLE">
<AU>Berry DJ</AU>
<TI>Unstable total hip arthroplasty: detailed overview</TI>
<SO>Instr Course Lect</SO>
<YR>2001</YR>
<VL>50</VL>
<PG>265-74</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Berry-2004" NAME="Berry 2004" TYPE="JOURNAL_ARTICLE">
<AU>Berry DJ, Von Knoch M, Schleck CD, Harmsen WS</AU>
<TI>The cumulative long-term risk of dislocation after primary charnley total hip arthroplasty</TI>
<SO>J Bone Joint Surg Am</SO>
<YR>2004</YR>
<VL>86</VL>
<NO>1</NO>
<PG>9-14</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Bremner-2003" NAME="Bremner 2003" TYPE="JOURNAL_ARTICLE">
<AU>Bremner BR, Goetz DD, Callaghan JJ, Capello WN, Johnston RC</AU>
<TI>Use of constrained acetabular components for hip instability: an average 10-year follow-up study</TI>
<SO>J Arthroplasty</SO>
<YR>2003</YR>
<VL>18</VL>
<NO>7 Suppl 1</NO>
<PG>131-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Bystrom-2003" NAME="Bystrom 2003" TYPE="JOURNAL_ARTICLE">
<AU>Bystrom S, Espehaug B, Furnes O, Havelin LI</AU>
<TI>Femoral head size is a risk factor for total hip luxation: a study of 42,987 primary hip arthroplasties from the Norwegian Arthroplasty Register</TI>
<SO>Acta Orthopaedica Scandinavica</SO>
<YR>2003</YR>
<VL>74</VL>
<NO>5</NO>
<PG>514-24</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Cabanela-2000" NAME="Cabanela 2000" TYPE="JOURNAL_ARTICLE">
<AU>Cabanela ME, Weber M</AU>
<TI>Total hip arthroplasty in patients with neuromuscular disease</TI>
<SO>Instr Course Lect</SO>
<YR>2000</YR>
<VL>49</VL>
<PG>163-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Cates-2004" NAME="Cates 2004" TYPE="COMPUTER_PROGRAM">
<AU>Chris Cates</AU>
<TI>Visual Rx 2.0 NNT Calculator</TI>
<YR>2004</YR>
<PB>Chris Cates EBM Website www.nntonline.net</PB>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Chandler-1982" MODIFIED="2008-11-07 13:06:56 -0500" MODIFIED_BY="[Empty name]" NAME="Chandler 1982" TYPE="JOURNAL_ARTICLE">
<AU>Chandler RW, Dorr LD, Perry J</AU>
<TI>The functional cost of dislocation following total hip arthroplasty</TI>
<SO>Clinical Orthopaedics and Related Research</SO>
<YR>1982</YR>
<VL>168</VL>
<PG>168-72</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Charlwood-2002" NAME="Charlwood 2002" TYPE="JOURNAL_ARTICLE">
<AU>Charlwood AP, Thompson NW, Thompson NS, Beverland DE, Nixon JR</AU>
<TI>Recurrent hip arthroplasty dislocation</TI>
<SO>Acta Orthopaedica Scandinavica</SO>
<YR>2002</YR>
<VL>73</VL>
<NO>5</NO>
<PG>502-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Cobb-1996" NAME="Cobb 1996" TYPE="JOURNAL_ARTICLE">
<AU>Cobb TK, Morrey BF, Ilstrup DM</AU>
<TI>The elevated-rim acetabular liner in total hip arthroplasty: relationship to postoperative dislocation</TI>
<SO>J Bone and Joint Surg Am</SO>
<YR>1996</YR>
<VL>78</VL>
<NO>1</NO>
<PG>80-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Daly-1992" NAME="Daly 1992" TYPE="JOURNAL_ARTICLE">
<AU>Daly PJ, Morrey BF</AU>
<TI>Operative correction of an unstable total hip arthroplasty</TI>
<SO>J Bone and Joint Surg Am</SO>
<YR>1992</YR>
<VL>74</VL>
<NO>9</NO>
<PG>1334-43</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Dorr-1983" MODIFIED="2008-11-07 13:06:34 -0500" MODIFIED_BY="[Empty name]" NAME="Dorr 1983" TYPE="JOURNAL_ARTICLE">
<AU>Dorr LD, Wolf AW, Chandler R, Conaty JP</AU>
<TI>Classification and treatment of dislocations of total hip arthroplasty</TI>
<SO>Clinical Orthopaedics and Related Research</SO>
<YR>1983</YR>
<VL>173</VL>
<PG>151-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ekelund-1992" NAME="Ekelund 1992" TYPE="JOURNAL_ARTICLE">
<AU>Ekelund A, Rydell N, Nilsson OS</AU>
<TI>Total hip arthroplasty in patients 80 years of age and older</TI>
<SO>Clinical Orthopaedics and Related Research</SO>
<YR>1992</YR>
<VL>281</VL>
<PG>101-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Fackler-1980" NAME="Fackler 1980" TYPE="JOURNAL_ARTICLE">
<AU>Fackler CD, Poss R</AU>
<TI>Dislocation in total hip arthroplasties</TI>
<SO>Clinical Orthopaedics and Related Research</SO>
<YR>1980</YR>
<VL>151</VL>
<PG>169-78</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Fujishiro-2003" NAME="Fujishiro 2003" TYPE="JOURNAL_ARTICLE">
<AU>Fujishiro T, Nishikawa T, Takikawa S, Saegusa Y, Yoshiya S, Kurosaka M</AU>
<TI>Reconstruction of the iliofemoral ligament with an artificial ligament for recurrent anterior dislocation of total hip arthroplasty</TI>
<SO>J Arthroplasty</SO>
<YR>2003</YR>
<VL>18</VL>
<NO>4</NO>
<PG>524-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Goetz-1998" NAME="Goetz 1998" TYPE="JOURNAL_ARTICLE">
<AU>Goetz DD, Capello WN, Callaghan JJ, Brown TD, Johnston RC</AU>
<TI>Salvage of a recurrently dislocating total hip prosthesis with use of a constrained acetabular component</TI>
<SO>J Bone Joint Surg Am</SO>
<YR>1998</YR>
<VL>80</VL>
<NO>4</NO>
<PG>502-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2005" NAME="Higgins 2005" TYPE="OTHER">
<AU>Higgins JPT, Green S</AU>
<TI>Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated May 2005]</TI>
<SO>In: The Cochrane Library</SO>
<YR>2005</YR>
<NO>3</NO>
<PB>John Wiley &amp; Sons, Ltd</PB>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Jadad-1996" NAME="Jadad 1996" TYPE="JOURNAL_ARTICLE">
<AU>Jadad AR, Moore RA, Carroll D, et al.</AU>
<TI>Assessing the quality of reports of randomized clinical trials: Is blinding necessary?</TI>
<SO>Controlled Clinical Trials</SO>
<YR>1996</YR>
<VL>17</VL>
<PG>1-12</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Joshi-1998" NAME="Joshi 1998" TYPE="JOURNAL_ARTICLE">
<AU>Joshi A, Lee CM, Markovic L, Vlatis G, Murphy JCM</AU>
<TI>Prognosis of dislocation after total hip arthroplasty</TI>
<SO>J Arthroplasty</SO>
<YR>1998</YR>
<VL>13</VL>
<NO>1</NO>
<PG>17-21</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Kaplan-1987" NAME="Kaplan 1987" TYPE="JOURNAL_ARTICLE">
<AU>Kaplan SJ, Thomas WH, Poss R</AU>
<TI>Trochanteric advancement for recurrent dislocation after total hip arthroplasty</TI>
<SO>J Arthroplasty</SO>
<YR>1987</YR>
<VL>2</VL>
<NO>2</NO>
<PG>119-24</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Lewinnek-1978" NAME="Lewinnek 1978" TYPE="JOURNAL_ARTICLE">
<AU>Lewinnek GE, Lewis JL, Tarr R, Compere CL, Zimmerman JR</AU>
<TI>Dislocations after total hip-replacement arthroplasties</TI>
<SO>J Bone and Joint Surg Am</SO>
<YR>1978</YR>
<VL>60</VL>
<NO>2</NO>
<PG>217-20</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Lombardi-1991" NAME="Lombardi 1991" TYPE="JOURNAL_ARTICLE">
<AU>Lombardi AV, Mallory TH, Kraus TJ, Vaughn BK</AU>
<TI>Preliminary report on the S-ROM constraining acetabular insert: a retrospective clinical experience</TI>
<SO>Orthopedics</SO>
<YR>1991</YR>
<VL>14</VL>
<NO>3</NO>
<PG>297-303</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Mahoney-2003" NAME="Mahoney 2003" TYPE="JOURNAL_ARTICLE">
<AU>Mahoney CR, Pellicci PM</AU>
<TI>Complications in primary total hip arthroplasty: avoidance and management of dislocations</TI>
<SO>Instr Course Lect</SO>
<YR>2003</YR>
<VL>52</VL>
<PG>247-55</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Masonis-2002" NAME="Masonis 2002" TYPE="JOURNAL_ARTICLE">
<AU>Masonis JL, Bourne RB</AU>
<TI>Surgical approach, abductor function, and total hip arthroplasty dislocation</TI>
<SO>Clinical Orthopaedics and Related Research</SO>
<YR>2002</YR>
<VL>405</VL>
<PG>46-53</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Olerud-1985" NAME="Olerud 1985" TYPE="JOURNAL_ARTICLE">
<AU>Olerud S, Karlstrom G</AU>
<TI>Recurrent dislocation after total hip replacement</TI>
<SO>J Bone Joint Surg Br</SO>
<YR>1985</YR>
<VL>67</VL>
<NO>3</NO>
<PG>402-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Parvizi-2000" NAME="Parvizi 2000" TYPE="JOURNAL_ARTICLE">
<AU>Parvizi J, Morrey BF</AU>
<TI>Bipolar hip arthroplasty as a salvage treatment for instability of the hip</TI>
<SO>J Bone Joint Surg Am</SO>
<YR>2000</YR>
<VL>82</VL>
<NO>8</NO>
<PG>1132-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Paterno-1997" NAME="Paterno 1997" TYPE="JOURNAL_ARTICLE">
<AU>Paterno SA, Lachiewicz PF, Kelley SS</AU>
<TI>The influence of patient-related factors and the position of the acetabular component on the rate of dislocation after total hip replacement</TI>
<SO>J Bone and Joint Surg Am</SO>
<YR>1997</YR>
<VL>79</VL>
<NO>8</NO>
<PG>1202-10</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ranawat-2000" NAME="Ranawat 2000" TYPE="CONFERENCE_PROC">
<AU>Ranawat CS, DiGiovanni C, Pellici P</AU>
<TI>Treatment of recurrent instability after hybrid total hip arthroplasty by cementingconstrained, all-polyethylene liners into well-fixed, metal backed shells: two-year results</TI>
<SO>AAOS, Poster PE071</SO>
<YR>2000</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ritter-1976" NAME="Ritter 1976" TYPE="JOURNAL_ARTICLE">
<AU>Ritter MA</AU>
<TI>Dislocation and subluxation of the total hip replacement</TI>
<SO>Clinical Orthopaedics and Related Research</SO>
<YR>1976</YR>
<VL>121</VL>
<PG>92-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Shapiro-2003" NAME="Shapiro 2003" TYPE="JOURNAL_ARTICLE">
<AU>Shapiro GS, Weiland DE, Markel DC, Padgett DE, Sculco TP, Pellici PM</AU>
<TI>The use of a constrained acetabular component for recurrent dislocation</TI>
<SO>J Arthroplasty</SO>
<YR>2003</YR>
<VL>18</VL>
<NO>3</NO>
<PG>250-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Shrader-2003" NAME="Shrader 2003" TYPE="JOURNAL_ARTICLE">
<AU>Shrader MW, Parvizi J, Lewallen DG</AU>
<TI>The use of a constrained acetabular component to treat instability after total hip arthroplasty</TI>
<SO>J Bone and Joint Surg Am</SO>
<YR>2003</YR>
<VL>85</VL>
<NO>11</NO>
<PG>2179-83</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Stanton-2002" NAME="Stanton 2002" TYPE="JOURNAL_ARTICLE">
<AU>Stanton DA, Bruce WJ, Goldberg JA, Walsh W</AU>
<TI>Salvaging unstable or recurrent dislocating total hip arthroplasty with the constrained acetabular component</TI>
<SO>J Orthop Surg (Hong Kong)</SO>
<YR>2002</YR>
<VL>10</VL>
<NO>2</NO>
<PG>165-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Stromsoe-1995" NAME="Stromsoe 1995" TYPE="JOURNAL_ARTICLE">
<AU>Stromsoe K, Eikvar K</AU>
<TI>Fascia lata plasty in recurrent posterior dislocation after total hip arthroplasty</TI>
<SO>Arch Orthop Trauma Surg</SO>
<YR>1995</YR>
<VL>114</VL>
<NO>5</NO>
<PG>292-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Su-2001" NAME="Su 2001" TYPE="JOURNAL_ARTICLE">
<AU>Su EP, Shapiro GS, Pellicci PM</AU>
<TI>The use of constrained acetabular sockets</TI>
<SO>Techniques in Orthopaedics</SO>
<YR>2001</YR>
<VL>16</VL>
<NO>3</NO>
<PG>237-44</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Tugwell-2004" NAME="Tugwell 2004" TYPE="BOOK">
<AU>Tugwell P, Shea B, Boers M, Brooks P, Simon L, Strand V, et al</AU>
<SO>Evidence Based Rheumatology</SO>
<YR>2004</YR>
<PB>BMJ Books</PB>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Turner-1994" NAME="Turner 1994" TYPE="JOURNAL_ARTICLE">
<AU>Turner RS</AU>
<TI>Postoperative total hip prosthetic femoral head dislocations. Incidence, etiologic factors, and management</TI>
<SO>Clinical Orthopaedics and Related Research</SO>
<YR>1994</YR>
<VL>301</VL>
<PG>196-204</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Williams-1982" NAME="Williams 1982" TYPE="JOURNAL_ARTICLE">
<AU>Williams JF, Gottesman MJ, Mallory TH</AU>
<TI>Dislocation after total hip arthroplasty. Treatment with an above-knee hip spica cast</TI>
<SO>Clinical Orthopaedics and Related Research</SO>
<YR>1982</YR>
<VL>171</VL>
<PG>53-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Woo-1982" NAME="Woo 1982" TYPE="JOURNAL_ARTICLE">
<AU>Woo RYG, Morrey BF</AU>
<TI>Dislocations after total hip arthroplasty</TI>
<SO>J Bone Joint Surg Am</SO>
<YR>1982</YR>
<VL>64</VL>
<NO>9</NO>
<PG>1295-306</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Woolson-1999" NAME="Woolson 1999" TYPE="JOURNAL_ARTICLE">
<AU>Woolson ST, Rahimtoola ZO</AU>
<TI>Risk factors for dislocation during the first 3 months after primary total hip replacement</TI>
<SO>J Arthroplasty</SO>
<YR>1999</YR>
<VL>14</VL>
<NO>6</NO>
<PG>662-8</PG>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES/>
<PENDING_REFERENCES/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES>
<CHARACTERISTICS_OF_INCLUDED_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES SORT_BY="STUDY">
<EXCLUDED_CHAR STUDY_ID="STD-Atlihan-2002">
<CHAR_REASON_FOR_EXCLUSION>
<P>RCT comparing 4 techniques for hip replacement in 40 patients with congenital dislocation of the hip</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Kelley-1998">
<CHAR_REASON_FOR_EXCLUSION>
<P>RCT evaluating the relationship betweem femoral head size / acetabular outer diameter and the prevalence of dislocation, in 30 patients</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Peak-2005">
<CHAR_REASON_FOR_EXCLUSION>
<P>RCT evaluating the role of patient restrictions in reducing the prevalence of early dislocation</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Toomey-2001">
<CHAR_REASON_FOR_EXCLUSION>
<P>Case series of 13 patients treated with modular component exchange, involving a combination of: use of a longer neck, larger head size, elevated liner rim, reorientaion of the liner or thicker liner</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES>
<P>RCT - Randomised controlled trial</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" NO="1">
<NAME>Adequate sequence generation?</NAME>
<DESCRIPTION>
<P>Was the allocation sequence adequately generated?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" NO="2">
<NAME>Allocation concealment?</NAME>
<DESCRIPTION>
<P>Was allocation adequately concealed?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" NO="3">
<NAME>Blinding?</NAME>
<DESCRIPTION>
<P>Was knowledge of the allocated interventions adequately prevented during the study?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" NO="4">
<NAME>Incomplete outcome data addressed?</NAME>
<DESCRIPTION>
<P>Were incomplete outcome data adequately addressed?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" NO="5">
<NAME>Free of selective reporting?</NAME>
<DESCRIPTION>
<P>Are reports of the study free of suggestion of selective outcome reporting?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" NO="6">
<NAME>Free of other bias?</NAME>
<DESCRIPTION>
<P>Was the study apparently free of other problems that could put it at a high risk of bias?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES/>
<ADDITIONAL_TABLES/>
<ANALYSES_AND_DATA CALCULATED_DATA="YES"/>
<FIGURES/>
<FEEDBACK/>
<APPENDICES MODIFIED="2008-11-07 13:04:02 -0500" MODIFIED_BY="[Empty name]">
<APPENDIX ID="APP-01" MODIFIED="2008-11-07 13:04:02 -0500" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2008-11-07 13:04:00 -0500" MODIFIED_BY="[Empty name]">MEDLINE search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2008-11-07 13:04:02 -0500" MODIFIED_BY="[Empty name]">
<P>1 arthroplasty, replacement, hip/<BR/>2 Hip Prosthesis/<BR/>3 or/1-2<BR/>4 arthroplasty/ or arthroplasty, replacement/<BR/>5 Joint Prosthesis/<BR/>6 "Prostheses and Implants"/<BR/>7 (arthroplasty or replacement or prosthes#s).tw.<BR/>8 or/4-7<BR/>9 hip/ or hip joint/ or hip.tw.<BR/>10 8 and 9<BR/>11 3 or 10<BR/>12 Hip Dislocation/<BR/>13 Joint Instability/<BR/>14 (displacment$ or dislocat$ or instabilit$ or unstable).tw.<BR/>15 9 and 14<BR/>16 or/12-15<BR/>17 11 and 16<BR/>18 clinical trial.pt.<BR/>19 randomized controlled trial.pt.<BR/>20 tu.fs.<BR/>21 dt.fs.<BR/>22 random$.tw.<BR/>23 (double adj blind$).tw.<BR/>24 placebo$.tw.<BR/>25 or/18-24<BR/>26 17 and 25</P>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS/>
</COCHRANE_REVIEW>